Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age, SARS-CoV-2 test, Tuberculin test
Clinical narrative: Red arm; Hard; Hot to the touch; Sore arm; Headache; 17 year old patient received first dose of Moderna COVID-19 vaccine; This spontaneous case was reported by a nurse and describes the occurrence of ERYTHEMA (Red arm), INDURATION (Hard), FEELING HOT (Hot to the touch), PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old patient received first dose of Moderna COVID-19 vaccine) and PAIN IN EXTREMITY (Sore arm) in a 17-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 033K21-2A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient had no ear infection or allergy flare-ups.  The patient's past medical history included Sexually transmitted infection (risk of sexually transmitted infection), Fracture of ankle, Ear infection (no recent ear infection.), Laryngitis, Vomiting, Urinary tract disorder (urinary symptoms) and COVID-19 (Tested positive to COVID a year ago (before the vaccine)) in 2021. Concurrent medical conditions included Anxiety, Asthma, Eczema, Family stress (family tension, lots of tension in the family), GERD, Generalized anxiety disorder (GAD), Insomnia (Recent change in status improvement sleeping okay), Migraine (migraines 3-4 a month), Photophobia, Posture abnormal (poor posture) and Tick bite. Concomitant products included ETHINYLESTRADIOL;NORETHINDRONE and ETHINYLESTRADIOL, NORETHISTERONE ACETATE (JUNEL) for Birth control, ALBUTEROL [SALBUTAMOL], FEXOFENADINE, FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]) and IBUPROFEN for an unknown indication.    On 04-Apr-2022, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) .5 milliliter. On 04-Apr-2022, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old patient received first dose of Moderna COVID-19 vaccine). On an unknown date, the patient experienced ERYTHEMA (Red arm), INDURATION (Hard), FEELING HOT (Hot to the touch), PAIN IN EXTREMITY (Sore arm) and HEADACHE (Headache). At the time of the report, ERYTHEMA (Red arm), INDURATION (Hard), FEELING HOT (Hot to the touch), PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old patient received first dose of Moderna COVID-19 vaccine), PAIN IN EXTREMITY (Sore arm) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, SARS-CoV-2 test: positive (Positive) Positive. On an unknown date, Tuberculin test: result not provided Result not provided.     For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments.   No other vaccines were administered within 1 month prior to Moderna COVID-19 vaccine Reporter states that her 17 year old daughter received the Moderna vaccine as the 1st shot, they were going to receive the 2nd dose from Pfizer at the time of report. No Treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2022: New Reporter added, Patient Initials updated. Medical History added. Lab data added. Concomitant medication (Junel) added. New events added.